Glutathione Complex uses pure Setria glutathione.** **Setria is a registered trademark of Kyowa Hakko Bio Co., Ltd
The medication requires ongoing use to maintain weight loss, as demonstrated in the SURMOUNT-4 trial, where discontinuation led to weight regain
Retatrutide remains an investigational medication and has not received FDA approval
Kosiborod MN, Petrie MC, Borlaug BA et al (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes
Clinical trials (ten studies, 419 participants) using doses from 400 mg to 10 g over 21 days to 20 months show consistent reductions in fasting glucose, post-meal glucose, and HbA1c
How PlexusDx Supports a More Personalized Approach PlexusDx genetic insights specifically address peptide pathway predispositions that may help provide context for how your metabolic system regulates appetite, glucose, and weight